ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years
Christina Lynn Roland
Matched on ORCID iD 0000-0003-3400-0087; OpenAlex author ID A5086634878. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 33
2013: 1 paper · 2014: 1 paper · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 6
- Discovering signature disease trajectories in pancreatic cancer and soft-tissue sarcoma from longitudinal patient records. Co-author DOI 10.1016/j.jbi.2025.104935↗
- The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy. Co-author DOI 10.1111/his.12732↗
- Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer. Co-author DOI 10.1245/s10434-014-4192-6↗
- The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy. Co-author DOI 10.1245/s10434-015-4854-z↗
- Targeting pancreatic ductal adenocarcinoma acidic microenvironment. First author DOI 10.1038/srep04410↗
- A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. First author DOI 10.1053/j.gastro.2013.08.018↗
Closest collaborators
The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Matthew H. G. Katz · 4 shared papers, 2015–2025 · strength 0.37
- Paper Discovering signature disease trajectories in pancreatic cancer and soft-tissue sarcoma from longitudinal patient recor… DOI 10.1016/j.jbi.2025.104935↗
- Paper The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pa… DOI 10.1111/his.12732↗
- Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
- Adriana Carolina Gamboa · 1 shared paper, 2025 · strength 0.23
- Hongfang Liu · 1 shared paper, 2025 · strength 0.23
- Liwei Wang · 1 shared paper, 2025 · strength 0.23
- Jason B. Fleming · 4 shared papers, 2013–2016 · strength 0.17
- Paper The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pa… DOI 10.1111/his.12732↗
- Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
- Paper The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Trea… DOI 10.1245/s10434-015-4854-z↗
- Robert A. Wolff · 3 shared papers, 2015–2016 · strength 0.14
- Paper The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pa… DOI 10.1111/his.12732↗
- Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
- Paper The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Trea… DOI 10.1245/s10434-015-4854-z↗
- Gauri Rajani Varadhachary · 3 shared papers, 2015–2016 · strength 0.14
- Paper The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pa… DOI 10.1111/his.12732↗
- Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
- Paper The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Trea… DOI 10.1245/s10434-015-4854-z↗
- Christopher H. Crane · 2 shared papers, 2015 · strength 0.09
- Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
- Paper The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Trea… DOI 10.1245/s10434-015-4854-z↗
- Jeffrey E. Lee · 2 shared papers, 2015 · strength 0.09
- Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
- Paper The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Trea… DOI 10.1245/s10434-015-4854-z↗
- Zobeida Cruz‐Monserrate · 2 shared papers, 2013–2014 · strength 0.08
- Craig D. Logsdon · 2 shared papers, 2013–2014 · strength 0.08
- Huamin Wang · 2 shared papers, 2013–2015 · strength 0.08
- Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
- Paper A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. DOI 10.1053/j.gastro.2013.08.018↗
- Deyali Chatterjee · 2 shared papers, 2013–2015 · strength 0.08
- Paper Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic ca… DOI 10.1245/s10434-014-4192-6↗
- Paper A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice. DOI 10.1053/j.gastro.2013.08.018↗
- Laurice K. Fischer · 1 shared paper, 2016 · strength 0.05
- Huamin Wang · 1 shared paper, 2016 · strength 0.05
- Li Liu · 1 shared paper, 2016 · strength 0.05
- Hua Wang · 1 shared paper, 2016 · strength 0.05
- Sun Mi Lee · 1 shared paper, 2016 · strength 0.05
- Jeannelyn Santiano Estrella · 1 shared paper, 2016 · strength 0.05
- Anirban Maitra · 1 shared paper, 2016 · strength 0.05
- Thiruvengadam Arumugam · 1 shared paper, 2014 · strength 0.04
- Rachna T. Shroff · 1 shared paper, 2015 · strength 0.04
- Milind M. Javle · 1 shared paper, 2015 · strength 0.04
- Anthony D. Yang · 1 shared paper, 2015 · strength 0.04
- Jean‐Nicolas Vauthey · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.